Dravet Syndrome Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Dravet Syndrome?
Dravet Syndrome is a developmental and epileptic encephalopathy that typically begins during the first year of life in an otherwise normally developing infant. Seizures are often prolonged, may be triggered by fever or changes in body temperature, and can become difficult to control. As the condition progresses, other seizure types, developmental delays, movement and coordination difficulties, behavioural concerns, and learning problems may develop.
What is the Importance of Timely Treatment?
Timely diagnosis and treatment help control seizures, reduce prolonged seizure episodes and seizure-related injuries, monitor developmental changes, and provide appropriate supportive therapies. Early specialist management is particularly important because some commonly used antiseizure medicines can worsen seizures in people with Dravet Syndrome.
What are the Common Symptoms of Dravet Syndrome?
- Prolonged Seizures: Seizures may last several minutes or longer and can require urgent medical management.
- Fever-Triggered Seizures: Seizures may be triggered by fever, illness, overheating, or sudden temperature changes.
- Multiple Seizure Types: Children may develop myoclonic, absence, focal, or other seizure types as the condition progresses.
- Developmental Difficulties: Development may slow, or developmental delays may become noticeable during early childhood.
- Movement and Coordination Problems: Some individuals develop balance, walking, coordination, or motor difficulties.
- Behavioural and Learning Difficulties: Attention, communication, learning, and behavioural challenges may occur as the condition progresses.
Causes and Risk Factors of Dravet Syndrome
Causes
- SCN1A Gene Variant: Most cases involve a pathogenic variant in the SCN1A gene, which plays an important role in neuronal sodium-channel function.
- Altered Neuronal Function: Changes in sodium-channel activity can disrupt the balance of electrical activity in the brain and increase seizure susceptibility.
- De Novo Genetic Changes: In most affected individuals, the SCN1A variant occurs spontaneously and is not inherited from either parent.
- Other Genetic Causes: A small proportion of patients may have Dravet-like epilepsy associated with other genetic abnormalities.
- Unknown Cause: In some clinically suspected cases, clinicians may not initially identify a specific genetic cause.
Risk Factors
- Early-Onset Seizures: Seizures beginning during infancy, particularly prolonged or hemiclonic seizures, are an important clinical feature.
- Fever-Associated Seizures: Seizures frequently associated with fever or temperature changes may raise suspicion.
- Family History: A family history is uncommon because most cases result from new genetic changes, although inherited SCN1A variants can occasionally occur.
- Seizure Characteristics: Prolonged, recurrent, or multiple seizure types during infancy may be associated with the condition.
Latest Research and Technologies in the Treatment of Dravet Syndrome in India
- Recent advances in Dravet Syndrome care include genetic testing, prolonged video-EEG monitoring, advanced brain imaging, precision seizure management, and newer antiseizure therapies. Research is also exploring gene-targeted treatments, antisense oligonucleotides, gene therapy approaches, and other therapies designed to address the underlying SCN1A-related neuronal dysfunction.
Treatment options for Dravet Syndrome
Treatment is individualised according to seizure type, age, genetic findings, treatment response, developmental status, and overall health. Options may include:
Antiseizure Medicines: Specialist-selected medicines are used to reduce seizure frequency and severity.
Ketogenic Diet Therapy: A medically supervised ketogenic diet may help reduce seizures in selected drug-resistant cases.
Vagus Nerve Stimulation : VNS may be considered for some patients whose seizures remain difficult to control.
Cost Start From 15000Explore Options
Emergency Seizure Treatment : Rescue medicines may be prescribed to manage prolonged or cluster seizures.
Cost Start From 3250Explore Options
Supportive Management: Developmental, behavioural, educational, nutritional, and functional therapies form an important part of long-term care.
- Clinical assessment:
- Seizure History: Detailed evaluation of seizure onset, duration, triggers, frequency, and different seizure types.
- Neurological Examination: Assessment of muscle tone, strength, reflexes, coordination, and neurological function.
- Developmental Assessment: Evaluation of cognitive, language, motor, and developmental progress.
- Behavioral Assessment: Assessment of attention, communication, behaviour, and emotional functioning.
- Medication Review: Evaluation of previous antiseizure medicines, response, and possible seizure aggravation.
- Functional Assessment: Assessment of mobility, daily activities, communication, and independence.
- Imaging Tests:
- Video EEG: Long-term EEG with video recording helps identify and classify different seizure types.
- Sleep EEG: Sleep recordings may reveal epileptiform abnormalities that are less apparent during wakefulness.
- Brain MRI: MRI can help identify structural abnormalities and exclude other causes of epilepsy.
- PET Scan: PET may be used in selected complex cases to assess brain metabolism.
- SPECT Scan: Consider SPECT during specialised epilepsy evaluation in selected patients.
- Genetic Testing: Molecular genetic testing, particularly evaluation of the SCN1A gene, can support diagnosis and guide management.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Dravet Syndrome patients in India. These services include:
- Depending on individual needs, it may include physiotherapy, occupational therapy, speech and language therapy, developmental therapy, behavioural support, nutritional guidance, and educational assistance.
- Medicines are central to Dravet Syndrome management and should be selected by an experienced epilepsy specialist. Treatment may include valproate, clobazam, stiripentol, fenfluramine, cannabidiol, and other appropriate antiseizure medicines. Some sodium-channel-blocking medicines may worsen seizures in Dravet Syndrome and are generally avoided unless specifically indicated by a specialist.
Instantly Connect with our Specialists
Hospitals for Dravet Syndrome in India
RATHIMED SPECIALITY HOSPITAL
Chennai, India
- Rathi Med Hospital possesses a great reputation as a centre for orthopaedics and reconstructive surgery for fractures of the knee, hip, spinal column and shoulder. It provides advanced methods for the treatment of various conditions of the knee such as arthritis, sports injuries, and other injuries related to joints, as well as other related conditions that affect mobility. The hospital has developed a unique treatment approach for knee preservation known as the KPA Knee Preservation 36? Approach. In the area of obstetrics and gynaecology, the hospital offers services related to painless delivery, cesarean birth, postnatal care, fertility care and overall wellness for women.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Dravet Syndrome Treatment?
- Experienced Epilepsy Specialists: India has pediatric neurologists, epileptologists, neurophysiologists, and multidisciplinary teams experienced in managing complex childhood epilepsy.
- Advanced Epilepsy Diagnostics: Leading centres may provide prolonged video-EEG, advanced MRI, genetic testing, and specialised epilepsy evaluation.
- Multiple Treatment Options: Eligible patients may have access to newer antiseizure medicines, ketogenic dietary therapy, VNS, and other treatment approaches.
- Genetic Evaluation: Specialist centres may offer genetic testing to identify SCN1A and other epilepsy-associated variants.
- Multidisciplinary Care: Neurology, genetics, rehabilitation, nutrition, psychology, developmental, and educational specialists may work together when required.
- Personalised Treatment: Treatment is tailored according to seizure type, genetic findings, age, development, and previous response to therapy.
- International Patient Support: Many major Indian hospitals assist international patients with appointments, treatment coordination, travel, accommodation, and follow-up.
Frequently Asked Questions
Dravet Syndrome is generally a lifelong neurological condition and does not have a fixed recovery period. Treatment focuses on reducing seizures, preventing complications, supporting development, and improving functional abilities over the long term.
Many children with Dravet Syndrome can walk, although developmental delays, balance problems, coordination difficulties, muscle tone abnormalities, or frequent seizures may affect mobility. Physiotherapy and appropriate seizure management can support safe movement and function.
Yes. Leading epilepsy centres in India may provide video-EEG monitoring, advanced MRI, genetic testing, specialised epilepsy evaluation, newer antiseizure therapies, ketogenic diet programmes, and neuromodulation such as VNS when appropriate
Many major Indian hospitals have international patient departments that assist with medical appointments, treatment coordination, travel arrangements, accommodation, interpretation, and follow-up care.
Consider the specialist's experience with Dravet Syndrome and drug-resistant childhood epilepsy, access to video-EEG and genetic testing, availability of appropriate antiseizure medicines, ketogenic dietary therapy, neuromodulation, multidisciplinary rehabilitation, and long-term follow-up.
There is no single success rate for Dravet Syndrome treatment because response varies between patients. Treatment aims to reduce seizure frequency and severity, limit prolonged seizures, prevent injuries, support development, and improve quality of life rather than provide a guaranteed cure.
India has pediatric neurologists, epileptologists, neurophysiologists, genetic specialists, and rehabilitation professionals who manage complex childhood and drug-resistant epilepsy, including patients with genetic epileptic encephalopathies.
Risks depend on the treatment used. Antiseizure medicines may cause adverse effects such as drowsiness, appetite or behavioral changes, while ketogenic therapy, VNS, and other interventions have treatment-specific risks. Regular specialist monitoring is important.
Dravet Syndrome is not an injury. If a seizure occurs, protect the person from injury, keep the surroundings clear, do not restrain them or place anything in their mouth, and follow their prescribed seizure emergency plan. Seek emergency medical help for a prolonged seizure, repeated seizures without recovery, breathing difficulties, or a serious injury.
Dravet Syndrome does not usually directly cause skeletal deformities. However, developmental difficulties, abnormal muscle tone, coordination problems, reduced mobility, and recurrent falls may contribute to long-term physical limitations in some individuals.
Yes. Frequent seizures, developmental and learning difficulties, movement problems, behavioural challenges, medication effects, and the need for ongoing supervision can affect education, independence, family life, and daily activities.
Poorly controlled Dravet Syndrome can lead to recurrent and prolonged seizures, seizure-related injuries, developmental difficulties, cognitive impairment, behavioural problems, movement and coordination difficulties, and reduced independence. Ongoing specialist care is important.
Dravet Syndrome cannot generally be prevented because most cases result from spontaneous genetic changes. However, early recognition of characteristic infantile seizures, genetic evaluation, appropriate antiseizure treatment, and avoidance of known seizure triggers can help reduce complications.
Dravet Syndrome usually begins during infancy and affects both males and females. It is most commonly associated with pathogenic SCN1A variants, which usually arise spontaneously rather than being inherited from a parent.